Xopenex
Product Images NDC 21695-153

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Xopenex (NDC 21695-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (35eb525b 72a5 4ef9 A36a 531e9e6b3560 01)

Chemical structure of the active ingredient in Xopenex, showing the molecular arrangement including hydroxyl (OH) groups, amine (NH) group, methyl (CH3) groups, and hydrochloride (HCl) component.*

FDA Label Image

Figure 1 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 02)

Line graph depicting the mean change in FEV1 (%) over time (hours) for four groups labeled Lev 1.25, Lev 0.63, Rac 2.5, and PBO. The x-axis shows time from pre-dose to 8 hours, and the y-axis shows percentage change in FEV1, with a dotted line marking 15% improvement. Each group is represented by distinct symbols and sample sizes are noted in the legend.*

FDA Label Image

Figure 2 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 03)

A line graph showing mean change in FEV1 (%) over time (hours) for four groups: Lev 1.25, Lev 0.63, Rac 2.5, and PBO. The graph depicts changes from 0 to 8 hours, with Lev 1.25 showing the highest peak response around 1 hour followed by a decline, and PBO showing minimal change throughout.*

FDA Label Image

Figure 3 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 04)

Line graph showing mean change in FEV1 (%) over time (hours) for five groups: Lev 0.63, Lev 0.31, Rac 2.5, Rac 1.25, and Pbo. Each line represents one group with data points from 0 to 4 hours, indicating variations in pulmonary function post-treatment.*

FDA Label Image

Figure 4 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 05)

A line graph depicting the mean change in FEV1 (%) over time (hours) for different treatment groups labeled Lev 0.63, Lev 0.31, Rac 2.5, Rac 1.25, and Pbo. Each line shows how lung function changes within a 4-hour period following administration, with data points plotted at intervals from 0 to 4 hours.*

FDA Label Image

Figure 1 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 06)

An instructional diagram of a unit-dose vial for Xopenex showing the twist-off tab portion. The shaded area highlights the part of the vial that needs to be twisted off to open it, with arrows pointing to the twist-off tabs on either side of the vial neck.*

FDA Label Image

Figure 2 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 07)

An instructional line drawing showing one hand holding a small vial or dropper bottle while the other hand peels or twists off a portion of the container's top. An arrow indicates the direction to pull or twist to open the vial.*

FDA Label Image

Figure 3 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 08)

An instructional illustration showing a hand pulling a cap or cover off a nasal spray or inhaler device. The image depicts the proper way to remove the cap before use, emphasizing the direction of removal with an arrow.*

FDA Label Image

Figure 4 (35eb525b 72a5 4ef9 A36a 531e9e6b3560 09)

Illustration showing a person using a handheld inhalation device with the mouthpiece positioned between the lips. The device is likely related to administration of the product Xopenex, demonstrating proper inhaler use technique.*

FDA Label Image

Xopenex 1.25mg/3ml (35eb525b 72a5 4ef9 A36a 531e9e6b3560 10)

Label for Xopenex 1.25 mg/3 ml unit-dose vials, containing 24 vials per package. The product is labeled by Rebel Distributors Corp, distributed by Physician Partner, Thousand Oaks, CA. The label includes dosage information, storage instructions at 15-30°C (59-86°F), and safety warnings to keep medication out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.